OXCT2 and Recurrent tonsillitis: Nearly half of the acute tonsillitis cases (452/1000) from the lowest PB risk group were predicted to be OXCT2 missense mutation carriers, which was a nearly threefold increase relative to the highest PB risk group (Fig. 7d).